PMC:7376974 / 18300-18905
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T78 | 59-62 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
| T79 | 250-253 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
| T80 | 416-425 | Body_part | denotes | G-protein | http://purl.org/sig/ont/fma/fma61788 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 223 | 59-64 | Species | denotes | HIV-1 | Tax:11676 |
| 224 | 90-95 | Species | denotes | HSV-2 | Tax:10310 |
| 225 | 102-129 | Species | denotes | respiratory syncytial virus | Tax:12814 |
| 226 | 250-255 | Species | denotes | HIV-1 | Tax:11676 |
| 229 | 131-134 | Species | denotes | RSV | Tax:12814 |
| 230 | 269-272 | Species | denotes | RSV | Tax:12814 |
| 234 | 167-173 | Chemical | denotes | carbon | MESH:D002244 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T44 | 66-80 | Disease | denotes | herpes simplex | http://purl.obolibrary.org/obo/MONDO_0004609 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T170 | 45-55 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
| T171 | 83-88 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T172 | 124-129 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T173 | 234-242 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T174 | 256-261 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T175 | 262-264 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T176 | 296-297 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T177 | 357-358 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T178 | 391-392 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T170 | 4-7 | Chemical | denotes | PVP | http://purl.obolibrary.org/obo/CHEBI_53245|http://purl.obolibrary.org/obo/CHEBI_53248 |
| T172 | 167-173 | Chemical | denotes | carbon | http://purl.obolibrary.org/obo/CHEBI_27594|http://purl.obolibrary.org/obo/CHEBI_33415 |
| T174 | 187-190 | Chemical | denotes | PVP | http://purl.obolibrary.org/obo/CHEBI_53245|http://purl.obolibrary.org/obo/CHEBI_53248 |
| T176 | 224-233 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T177 | 274-277 | Chemical | denotes | PVP | http://purl.obolibrary.org/obo/CHEBI_53245|http://purl.obolibrary.org/obo/CHEBI_53248 |
| T179 | 418-425 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T180 | 509-524 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
| T181 | 509-518 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T182 | 519-524 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T183 | 550-554 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T184 | 580-585 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T33 | 550-565 | http://purl.obolibrary.org/obo/GO_0042493 | denotes | drug resistance |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T119 | 0-605 | Sentence | denotes | The PVP-coated AgNPs are able to inhibit the activities of HIV-1, herpes simplex 2 virus (HSV-2), and respiratory syncytial virus (RSV).11,26,27 But compared to foamy carbon, small-sized PVP and BSA-coated AgNPs showed poor antiviral activity to the HIV-1 virus.11 For RSV, PVP-coated AgNPs have a specific binding capacity to the viral surface, evidencing a regular spatial arrangement and a clear interaction with G-protein.26 In addition, to improve the stability of AgNPs, their surface modification with antiviral drugs was proved to reduce the drug resistance caused by the drugs administered alone. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T3 | 550-565 | Phenotype | denotes | drug resistance | http://purl.obolibrary.org/obo/HP_0020174 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32667191-24682984-153283 | 142-144 | 24682984 | denotes | 27 |